Repository logo
 

Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19.

Simple item page
cam.issuedOnline2021-04-09
cam.orpheus.counter4
cam.orpheus.successMon Apr 19 07:30:52 BST 2021 - Embargo updated
datacite.isderivedfrom.doi10.1101/2020.11.19.20234120
dc.contributor.authorGaziano, Liam
dc.contributor.authorGiambartolomei, Claudia
dc.contributor.authorPereira, Alexandre C
dc.contributor.authorGaulton, Anna
dc.contributor.authorPosner, Daniel C
dc.contributor.authorSwanson, Sonja A
dc.contributor.authorHo, Yuk-Lam
dc.contributor.authorIyengar, Sudha K
dc.contributor.authorKosik, Nicole M
dc.contributor.authorVujkovic, Marijana
dc.contributor.authorGagnon, David R
dc.contributor.authorBento, A Patrícia
dc.contributor.authorBarrio-Hernandez, Inigo
dc.contributor.authorRönnblom, Lars
dc.contributor.authorHagberg, Niklas
dc.contributor.authorLundtoft, Christian
dc.contributor.authorLangenberg, Claudia
dc.contributor.authorPietzner, Maik
dc.contributor.authorValentine, Dennis
dc.contributor.authorGustincich, Stefano
dc.contributor.authorTartaglia, Gian Gaetano
dc.contributor.authorAllara, Elias
dc.contributor.authorSurendran, Praveen
dc.contributor.authorBurgess, Stephen
dc.contributor.authorZhao, Jing Hua
dc.contributor.authorPeters, James E
dc.contributor.authorPrins, Bram P
dc.contributor.authorAngelantonio, Emanuele Di
dc.contributor.authorDevineni, Poornima
dc.contributor.authorShi, Yunling
dc.contributor.authorLynch, Kristine E
dc.contributor.authorDuVall, Scott L
dc.contributor.authorGarcon, Helene
dc.contributor.authorThomann, Lauren O
dc.contributor.authorZhou, Jin J
dc.contributor.authorGorman, Bryan R
dc.contributor.authorHuffman, Jennifer E
dc.contributor.authorO'Donnell, Christopher J
dc.contributor.authorTsao, Philip S
dc.contributor.authorBeckham, Jean C
dc.contributor.authorPyarajan, Saiju
dc.contributor.authorMuralidhar, Sumitra
dc.contributor.authorHuang, Grant D
dc.contributor.authorRamoni, Rachel
dc.contributor.authorBeltrao, Pedro
dc.contributor.authorDanesh, John
dc.contributor.authorHung, Adriana M
dc.contributor.authorChang, Kyong-Mi
dc.contributor.authorSun, Yan V
dc.contributor.authorJoseph, Jacob
dc.contributor.authorLeach, Andrew R
dc.contributor.authorEdwards, Todd L
dc.contributor.authorCho, Kelly
dc.contributor.authorGaziano, J Michael
dc.contributor.authorButterworth, Adam S
dc.contributor.authorCasas, Juan P
dc.contributor.authorVA Million Veteran Program COVID-19 Science Initiative
dc.contributor.orcidGiambartolomei, Claudia [0000-0003-2786-1225]
dc.contributor.orcidGaulton, Anna [0000-0003-2634-7400]
dc.contributor.orcidPosner, Daniel C [0000-0002-3056-6924]
dc.contributor.orcidKosik, Nicole M [0000-0003-1384-7035]
dc.contributor.orcidVujkovic, Marijana [0000-0003-4924-5714]
dc.contributor.orcidGagnon, David R [0000-0002-6367-3179]
dc.contributor.orcidBento, A Patrícia [0000-0003-1424-480X]
dc.contributor.orcidRönnblom, Lars [0000-0001-9403-6503]
dc.contributor.orcidHagberg, Niklas [0000-0003-2064-2716]
dc.contributor.orcidLundtoft, Christian [0000-0001-5872-4253]
dc.contributor.orcidLangenberg, Claudia [0000-0002-5017-7344]
dc.contributor.orcidPietzner, Maik [0000-0003-3437-9963]
dc.contributor.orcidGustincich, Stefano [0000-0002-2749-2514]
dc.contributor.orcidTartaglia, Gian Gaetano [0000-0001-7524-6310]
dc.contributor.orcidAllara, Elias [0000-0002-1634-8330]
dc.contributor.orcidBurgess, Stephen [0000-0001-5365-8760]
dc.contributor.orcidPeters, James E [0000-0002-9415-3440]
dc.contributor.orcidPrins, Bram P [0000-0001-5774-034X]
dc.contributor.orcidHuffman, Jennifer E [0000-0002-9672-2491]
dc.contributor.orcidO'Donnell, Christopher J [0000-0002-2667-8624]
dc.contributor.orcidBeltrao, Pedro [0000-0002-2724-7703]
dc.contributor.orcidChang, Kyong-Mi [0000-0001-6811-9364]
dc.contributor.orcidSun, Yan V [0000-0002-2838-1824]
dc.contributor.orcidButterworth, Adam S [0000-0002-6915-9015]
dc.date.accessioned2021-03-17T00:30:11Z
dc.date.available2021-03-17T00:30:11Z
dc.date.issued2021-04
dc.description.abstractDrug repurposing provides a rapid approach to meet the urgent need for therapeutics to address COVID-19. To identify therapeutic targets relevant to COVID-19, we conducted Mendelian randomization analyses, deriving genetic instruments based on transcriptomic and proteomic data for 1,263 actionable proteins that are targeted by approved drugs or in clinical phase of drug development. Using summary statistics from the Host Genetics Initiative and the Million Veteran Program, we studied 7,554 patients hospitalized with COVID-19 and >1 million controls. We found significant Mendelian randomization results for three proteins (ACE2, P = 1.6 × 10-6; IFNAR2, P = 9.8 × 10-11 and IL-10RB, P = 2.3 × 10-14) using cis-expression quantitative trait loci genetic instruments that also had strong evidence for colocalization with COVID-19 hospitalization. To disentangle the shared expression quantitative trait loci signal for IL10RB and IFNAR2, we conducted phenome-wide association scans and pathway enrichment analysis, which suggested that IFNAR2 is more likely to play a role in COVID-19 hospitalization. Our findings prioritize trials of drugs targeting IFNAR2 and ACE2 for early management of COVID-19.
dc.description.sponsorshipWe are grateful to the Host Genetic Initiative for making their data publicly available (full acknowledgements can be found here: https://www.covid19hg.org/acknowledgements/). This research is based on data from the Million Veteran Program, Office of Research and Development, Veterans Health Administration, and was supported by award #MVP035. This research was also supported by additional Department of Veterans Affairs awards grant #MVP001. This publication does not represent the views of the Department of Veteran Affairs or the United States Government. Full acknowledgements for the VA Million Veteran Program COVID-19 Science Initiative can be found in the supplementary methods. C.G. has received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No 754490 – MINDED project. A.G., P.B. and A.R.L. are funded by the Member States of the European Molecular Biology Laboratory (EMBL). I.B.- H. received funding from Open Targets (grant agreement OTAR-044). The Fenland Study (10.22025/2017.10.101.00001) is funded by the Medical Research Council (MC_UU_12015/1); we are grateful to all the volunteers and to the General Practitioners and practice staff for assistance with recruitment; we thank the Fenland Study Investigators, Fenland Study Co-ordination team and the Epidemiology Field, Data and Laboratory teams; we further acknowledge support for genomics from the Medical Research Council (MC_PC_13046); proteomic measurements were supported and governed by a collaboration agreement between the University of Cambridge and Somalogic. J.E.P. is supported by UKRI Innovation Fellowship at Health Data Research UK (MR/S004068/2). L.R., N.H. and C.L. are supported by the Swedish Research Council. E.A. was supported by the EU/EFPIA Innovative Medicines Initiative Joint Undertaking BigData@Heart grant n° 116074 and by the British Heart Foundation Programme Grant RG/18/13/33946. We thank Dr. Angela Wood for feedback on statistical analyses used in the paper. We thank the INTERVAL Study investigators, co-ordination team and the epidemiology field, data and laboratory teams, which were supported by core funding from the UK Medical Research Council (MR/L003120/1), the British Heart Foundation (RG/13/13/30194; RG/18/13/33946), the NIHR Cambridge Biomedical Research Centre (BRC-1215-20014) [The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care], and the NIHR Blood and Transplant Research Unit in Donor Health and Genomics (NIHR BTRU-2014-10024). This work was also supported by Health Data Research UK, which is funded by the UK Medical Research Council, the Engineering and Physical Sciences Research Council, the Economic and Social Research Council, the Department of Health and Social Care (England), the Chief Scientist Office of the Scottish Government Health and Social Care Directorates, the Health and Social Care Research and Development Division (Welsh Government), the Public Health Agency (Northern Ireland), the British Heart Foundation, and Wellcome. J.D. holds a British Heart Foundation Professorship and a National Institute for Health Research Senior Investigator Award
dc.format.mediumPrint-Electronic
dc.identifier.doi10.17863/CAM.65974
dc.identifier.eissn1546-170X
dc.identifier.issn1078-8956
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/318859
dc.languageeng
dc.language.isoeng
dc.publisherSpringer Science and Business Media LLC
dc.publisher.urlhttp://dx.doi.org/10.1038/s41591-021-01310-z
dc.rightsAll rights reserved
dc.subjectAngiotensin-Converting Enzyme 2
dc.subjectCOVID-19
dc.subjectDrug Repositioning
dc.subjectGenome-Wide Association Study
dc.subjectHumans
dc.subjectInterleukin-10 Receptor beta Subunit
dc.subjectMendelian Randomization Analysis
dc.subjectQuantitative Trait Loci
dc.subjectReceptor, Interferon alpha-beta
dc.subjectSARS-CoV-2
dc.subjectCOVID-19 Drug Treatment
dc.titleActionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19.
dc.typeArticle
dcterms.dateAccepted2021-03-05
prism.endingPage676
prism.issueIdentifier4
prism.publicationDate2021
prism.publicationNameNat Med
prism.startingPage668
prism.volume27
pubs.funder-project-idMedical Research Council (MC_UU_12015/1)
pubs.funder-project-idBritish Heart Foundation (RG/18/13/33946)
pubs.funder-project-idWellcome Trust (204623/Z/16/Z)
pubs.funder-project-idMedical Research Council (MC_UU_00002/7)
pubs.funder-project-idMedical Research Council (MR/L003120/1)
pubs.funder-project-idBritish Heart Foundation (None)
pubs.funder-project-idNational Institute for Health and Care Research (IS-BRC-1215-20014)
rioxxterms.licenseref.startdate2021-04-09
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.typeJournal Article/Review
rioxxterms.versionAM
rioxxterms.versionofrecord10.1038/s41591-021-01310-z

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Gaziano_et_al_NatMed_2020_Accepted_version.pdf
Size:
7.26 MB
Format:
Adobe Portable Document Format
Description:
Accepted version
Licence
http://www.rioxx.net/licenses/all-rights-reserved
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
DepositLicenceAgreementv2.1.pdf
Size:
150.9 KB
Format:
Adobe Portable Document Format
Download

Collections

Cambridge University Research Outputs